Consumer Association Urges Malaysia to Ban E-cigarettes to Prevent Nicotine Addiction among Children

Sep.25.2022
Consumer Association Urges Malaysia to Ban E-cigarettes to Prevent Nicotine Addiction among Children
Consumer group urges Malaysia to ban e-cigarettes to prevent nicotine addiction among children, citing health risks and easy access.

The Consumers Association of Penang in Malaysia is urging the Ministry of Health to immediately ban all electronic cigarette products to prevent a large number of children from becoming addicted to nicotine.


According to data from the World Health Organization, electronic cigarettes contain nicotine and other toxic substances, which have a significant impact on users who are exposed to second-hand aerosols. Nicotine is a highly addictive substance and there is evidence to suggest that non-smoking minors who use e-cigarettes are twice as likely to smoke traditional cigarettes later in life.


According to research by CAP, children in Malaysia are able to easily purchase cheap electronic cigarettes because sellers do not inquire about the buyer's age. Children as young as 8 years old can purchase vaping devices and multiple children may even share one.


Mohideen Abdul Kader, a member of the Consumers Association of Penang (CAP), stated in a letter that although electronic nicotine delivery systems were only commercialized in Malaysia in early 2015, the number of people using these products in the country has increased from 600,000 in 2016 to 1.2 million in 2019. The National Treatment Centre (University of Malaya in George Town) reported approximately 30 cases of e-cigarette-related poisoning from 2015 to 2020, with most occurring in children aged 1-4 who are at high risk of death after ingesting e-cigarette liquid.


In Malaysia, the incidence of childhood cancer among children under 15 is nearly 77.4 cases per one million. Several studies have shown an increasing risk of cancer among those who use electronic cigarettes, or vaping. A study published in February 2022 found that vapers faced a higher risk of cancer than non-smokers. Evidence also suggests that US males and females aged 18 and above with a history of vaping are at a higher risk of bladder and lung cancer compared to those who have never smoked. Preclinical studies on mice exposed to e-cigarette vapors have shown increased incidence of lung adenocarcinoma and bladder urothelial hyperplasia.


Moon-shong Tang, from the New York University School of Medicine, has commented that "users of e-cigarettes, regardless of their age, have a higher risk of developing cancer than non-users". He told Lancet Oncology that in order to control childhood cancer, Malaysia should "prohibit the sale of e-cigarettes to minors".


According to Subbarow, over 20 countries have banned the sale of electronic cigarette products, and other nations including Australia, Norway and Canada have also implemented restrictions.


Malaysia's Health Minister, Khairy Jamaluddin, has proposed the "2022 Tobacco and Vaping Control Bill," which will impose fines on individuals born on or after January 1st, 2007, who sell tobacco or e-cigarette products. The bill is aimed at curbing the usage of tobacco and vaping products among younger generations.


Statement:


The content of this article has been compiled from third-party information and is intended solely for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the content. The compilation of this article is only intended for industry communication and research.


Due to limitations in the level of translation, the translated article may not fully reflect the original meaning. Please refer to the original text for accuracy.


2FIRSTS is fully aligned with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign issues, statements, and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Attorney General Stephen J. Cox has sent notices to more than 1,500 tobacco retailers and distributors warning them against selling vape and nicotine pouch products that lack authorization from the U.S. Food and Drug Administration (FDA). According to the Alaska Department of Law, businesses were advised to verify products against FDA authorization databases and avoid selling unauthorized nicotine products. The action highlights how state-level enforcement is increasingly extending federal product authorization requirements to retail channels.
Jul.24
Sesh touts independence, 8VC backing and retail reach as it challenges tobacco-owned pouch brands
Sesh touts independence, 8VC backing and retail reach as it challenges tobacco-owned pouch brands
U.S. nicotine pouch brand Sesh has emphasized its independence from Altria, Philip Morris International and British American Tobacco, along with backing from investors including 8VC, celebrity supporters and a retail footprint of more than 7,500 stores, as it seeks to differentiate itself in a market where major pouch brands are owned by large tobacco companies.
Regulations
Jul.07 by 2Firsts Perspectives
Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
U.S. Senator Ron Wyden, the Democratic ranking member of the Senate Finance Committee, has launched an investigation into flavored vape policy changes and requested records from the Department of Health and Human Services (HHS), Reynolds American and Botanic Tonics. The investigation focuses on a timeline involving Reynolds American’s $5 million donation to MAGA Inc. in April 2026 and subsequent vape policy developments. Wyden said the review aims to examine potential links between political donations, corporate communications and government decisions. The investigation does not represent a finding of wrongdoing.
Innovation
Aug.07 by 2Firsts Perspectives
Product | APUS Launches Chloe 50K, Bringing Purse-Inspired Design to the U.S. High-Puff Disposable Market
Product | APUS Launches Chloe 50K, Bringing Purse-Inspired Design to the U.S. High-Puff Disposable Market
APUS has introduced the Chloe 50K disposable vape, which has appeared across U.S.-facing online retail channels including Element Vape and Vapesourcing. The device combines a purse-inspired body and chain attachment with a 20ml e-liquid capacity, 1,250mAh rechargeable battery, dual mesh coil, and battery and e-liquid indicators. It is rated for up to 50,000 puffs. The product does not appear on the FDA’s current list of authorized e-cigarettes, and U.S. retail availability does not indicate FDA marketing authorization.
Jul.15
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland’s Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026 has passed final stage in the Dáil and will move to the Seanad, with measures to limit vape flavours to tobacco or unflavoured products and tighten rules on packaging colours, retail advertising, in-store displays and sales of nicotine pouches to minors.
News
Jun.26 by 2Firsts Perspectives
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts held its 2026 U.S. Market Compliance and Development Mid-Year Briefing in Shenzhen, China, on July 28. The discussion examined how state-level requirements, proposed foreign-establishment registration rules and expanding supply-chain responsibilities are changing product and investment decisions in the U.S. tobacco and nicotine market.
Jul.29